62
Wang L, et al. Sci China Chem January (2011) Vol.54 No.1
24.1, 27.9, 42.1, 52.5, 55.3, 55.7, 81.1, 110.5, 120.3, 128.1,
2 Experimental
128.6, 128.9, 156.5, 170.7. HRMS-ESI (m/z): [M + H]+
2.1 General information
calcd for C18H30N1O4S1, 356.1883; found, 356.1890.
1
3e H NMR (300 MHz, CDCl3): 1.23 (s, 9H), 1.41 (s,
THF was distilled from sodium/benzophenone. CH2I2 and
tert-butyl bromoacetate were distilled in vacuum. Reactions
were monitored by thin layer chromatography (TLC) on
glass plates coated with silica gel with fluorescent indicator
(Huanghai HSGF254). Flash chromatography was per-
formed on silicagel (Huanghai 300–400) with hexane/
EtOAc as eluent. Mass spectra were recorded on HP-5989
instrument and HRMS were measured on a Finnigan
MA+mass spectrometer. NMR spectra were recorded on a
Varian or a Bruker spectrometer (300 MHz), and chemical
shifts are reported in (ppm) referenced to an internal TMS
standard 1HNMR and CDCl3 (77.0 ppm) for 13CNMR.
9H), 2.75 (d, 2H, J = 6.3 Hz), 3.80 (s, 3H), 4.63 (d, 1H, J=
2.7 Hz), 4.70–4.75 (m, 1H), 6.81–6.93 (m, 3H), 7.22–7.27
(m, 1H). 13C NMR (75 MHz, CDCl3): 22.6, 28.0, 43.6,
55.2, 55.5, 55.6, 81.7, 112.8, 113.3, 119.6, 129.5, 142.5, 159.7,
170.4. HRMS-ESI (m/z): [M + H]+ calcd for C18H30N1O4S1,
356.1883; found, 356.1890.
1
3f H NMR (300 MHz, CDCl3): 1.21 (s, 9H), 1.40 (s,
9H), 2.73 (m, 2H), 3.80 (s, 3H), 4.56 (d, 1H, J = 2.7 Hz),
4.68–4.73 (m, 1H), 6.86 (d, 2H, J =8.7 Hz), 7.25 (d, 2H, J=
8.7 Hz). 13C NMR (75 MHz, CDCl3): 22.6, 28.0, 43.6,
54.9, 55.2, 55.5, 81.6, 113.8, 128.5, 132.6, 159.1, 170.5.
HRMS-ESI (m/z): [M + H]+ calcd for C18H30N1O4S1,
356.1883; found, 356.1890.
2.2 Starting materials procedure
1
3g H NMR (300 MHz, CDCl3): 1.23 (s, 9H), 1.40 (s,
9H), 2.74 (d, 2H, J = 6.3 Hz), 4.65 (d, 1H, J = 3.9 Hz),
4.66–4.76 (m, 1H), 7.27–7.34 (m, 4H). 13C NMR (75 MHz,
CDCl3): 22.6, 28.0, 29.7, 43.3, 55.0, 55.7, 81.9, 128.7,
133.6, 139.3, 170.2. HRMS-ESI (m/z): [M + H]+ calcd for
C17H27Cl1N1O3S1, 360.1400; found, 360.1395.
Chiral N-tert-butanesulfinyl imines (1a–i) were prepared
from the chiral tert-butanesulfinamide and the correspond-
ing aldehydes by the known method [23, 24].
2.3 General procedure for asymmetric synthesis of -
amino acid esters and characterization
1
3h H NMR (300 MHz, CDCl3): 1.22 (s, 9H), 1.37 (s,
9H), 2.83 (m, 2H, J = 6.0 Hz), 4.74 (d, 1H, J = 4.8 Hz),
4.77–4.83 (m, 1H), 7.27–7.32 (m, 1H), 7.67 (d, 1H, J = 7.2
Hz), 8.55 (d, 1H, J = 4.8 Hz), 8.63 (s, 1H). 13C NMR (75
MHz, CDCl3): 22.6, 27.9, 43.0, 53.6, 55.9, 82.1, 123.4,
135.1, 136.4, 148.9, 149.1, 170.0. HRMS-ESI (m/z): [M +
H]+ calcd for C16H27N2O3S1, 327.1738; found, 327.1737.
CH2I2 (0.8 mmol) was added at room temperature to a
Schlenk flask containing samarium powder (0.8 mmol) and
freshly distilled THF (3 mL) under nitrogen. After stirring
for 30 min at rt, the dark green colored mixture was cooled
to 78 °C. Then N-tert-butanesulfinyl imine (0.2 mmol) was
added, followed by tert-butyl bromoacetate (0.4 mmol, dis-
solved in 1 mL THF) being added dropwise over 10 min.
The resulting mixture was stirred at 78 °C for 2 h,
quenched with aqueous NH4Cl, and extracted with ethyl
acetate. The combined organic layers were dried over anhy-
drous Na2SO4, filtered, and concentrated. The residue was
purified by silica gel column chromatography to afford the
corresponding -amino acid esters 3.
1
3i H NMR (300 MHz, CDCl3): 1.22 (s, 9H), 1.37 (s,
9H), 2.97–3.00 (m, 2H), 4.75 (d, 1H, J = 3.9 Hz), 5.53–5.59
(m, 1H), 7.43–7.59 (m, 4H), 7.79 (d, 1H, J = 8.1 Hz), 7.87
(d, 1H, J = 8.4 Hz), 8.18 (d, 1H, J = 8.4 Hz). 13C NMR (75
MHz, CDCl3): 22.6, 27.9, 29.7, 42.8, 52.6, 55.8, 81.6,
123.2, 125.0, 125.2, 125.7, 126.3, 128.5, 129.0, 130.7,
133.9, 136.2, 170.6. HRMS-ESI (m/z): [M + H]+ calcd for
C21H30 N1O3S1, 376.1956; found, 376.1941.
1
3b H NMR (300 MHz, CDCl3): 1.24 (s, 9H), 1.41 (s,
9H), 2.79 (d, 2H, J = 6.3 Hz), 4.63 (d, 1H, J = 3.6 Hz),
4.74–4.80 (m, 1H), 7.28–7.36 (m, 5H). 13C NMR (75 MHz,
CDCl3): 22.6, 28.0, 43.6, 55.6, 81.6, 127.3, 127.8, 128.5,
140.7, 170.4.
2.4 General procedure for synthesis of -lactam 4 and
characterization
Compound 3 (0.3 mmol) was added to a solution of HCl in
dioxane (4 N, 10 mL) and the mixture was stirred at room
temperature for 0.5 h. After removing the solvent in vacuum,
the resulting crude product was dissolved in CH3CN (30 mL),
followed by the addition of NaHCO3 (151 mg, 1.8 mmol)
and MsCl (92 L, 1.2 mmol). The mixture was further
stirred at 60 °C for 8 h, then quenched with H2O (10 mL). The
solution was extracted with ethyl acetate. The combined
organic layers were dried over anhydrous Na2SO4, filtered,
and concentrated. The residue was purified by column
chromatography on silica gel to afford the corresponding
-lactam 4.
1
3c H NMR (300 MHz, CDCl3): 1.21 (s, 9H), 1.39 (s,
9H), 2.43 (s, 3H), 2.73–2.77 (m, 2H), 4.55 (d, 1H, J = 4.5
Hz), 4.50–5.03 (m, 1H), 7.17–7.21 (m, 3H), 7.32–7.35 (m,
1H). 13C NMR (75 MHz, CDCl3): 19.4, 22.6, 27.9, 42.6,
51.5, 55.6, 81.5, 126.1, 126.7, 127.6, 130.6, 135.9, 138.5,
170.5. HRMS-ESI (m/z): [M + H]+ calcd for C18H30N1O3S1,
340.1939; found, 340.1941.
1
3d H NMR (300 MHz, CDCl3): 1.21 (s, 9H), 1.36 (s,
9H), 2.88 (dd, 2H, J=6.3 Hz, J=2.7 Hz ), 3.87 (s, 3H), 4.74
(d, 1H, J = 7.2 Hz), 5.00–5.07 (m, 1H), 6.87–6.95 (m, 2H),
7.26–7.30 (m, 2H). 13C NMR (75 MHz, CDCl3): 22.6,